Steven Cohen Agios Pharmaceuticals, Inc. Transaction History

Point72 Asset Management, L.P.

$36.6 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$52.06 - $61.27 $5.26 Million - $6.19 Million	-101,100 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$44.23 - $57.5 $3.47 Million - $4.51 Million	-78,500 Reduced 43.71%	101,100 $5.22 Million
Q4 2020 Feb 16, 2021	SELL	$33.21 - $46.54 $9.9 Million - $13.9 Million	-298,252 Reduced 62.42%	179,600 $7.78 Million
Q3 2020 Nov 16, 2020	BUY	$33.87 - $55.93 $4.9 Million - $8.09 Million	144,593 Added 43.39%	477,852 $16.7 Million
Q2 2020 Aug 14, 2020	BUY	$34.45 - $53.48 $6.98 Million - $10.8 Million	202,645 Added 155.15%	333,259 $17.8 Million
Q1 2020 May 15, 2020	BUY	$31.52 - $53.81 $4.12 Million - $7.03 Million	130,614 New	130,614 $4.63 Million
Q3 2019 Nov 15, 2019	SELL	$32.4 - $49.58 $218,797 - $334,813	-6,753 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$46.17 - $68.1 $4.88 Million - $7.2 Million	-105,705 Reduced 94.0%	6,753 $337,000
Q1 2019 May 15, 2019	SELL	$45.92 - $67.67 $1.95 Million - $2.88 Million	-42,542 Reduced 27.45%	112,458 $7.58 Million
Q4 2018 Feb 14, 2019	SELL	$42.73 - $76.53 $884,510 - $1.58 Million	-20,700 Reduced 11.78%	155,000 $7.15 Million
Q3 2018 Nov 14, 2018	BUY	$71.67 - $91.95 $1.47 Million - $1.88 Million	20,500 Added 13.21%	175,700 $13.6 Million
Q2 2018 Aug 14, 2018	SELL	$73.22 - $99.55 $18.4 Million - $25 Million	-250,890 Reduced 61.78%	155,200 $13.1 Million
Q1 2018 May 15, 2018	BUY	$59.83 - $86.53 $18.8 Million - $27.2 Million	314,590 Added 343.81%	406,090 $33.2 Million
Q4 2017 Feb 14, 2018	SELL	$52.12 - $72.33 $1.99 Million - $2.76 Million	-38,140 Reduced 29.42%	91,500 $5.23 Million
Q3 2017 Nov 14, 2017	BUY	$54.89 - $67.12 $7.12 Million - $8.7 Million	129,640	129,640 $8.65 Million

Others Institutions Holding AGIO

# of Institutions

237

Shares Held

57.1M

Call Options Held

374K

Put Options Held

394K

Farallon Capital Management LLC San Francisco, CA

5.66M
Shares

$189 Million
1.26% of portfolio
Vanguard Group Inc Valley Forge, PA

5.63M
Shares

$188 Million
0.0% of portfolio
Black Rock Inc. New York, NY

4.86M
Shares

$162 Million
0.0% of portfolio
Bellevue Group Ag Kuesnacht, V8

3.74M
Shares

$124 Million
2.8% of portfolio
Price T Rowe Associates Inc Baltimore, MD

2.83M
Shares

$94.3 Million
0.01% of portfolio

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.83B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account